Coexpression of flt-1, flt-4 and KDR in freshly isolated and cultured human endothelial cells

被引:51
作者
Hewett, PW
Murray, JC
机构
[1] Univ. Nottingham Lab. Molec. Oncol., CRC Dept. of Clinical Oncology, City Hospital, Nottingham, NG5, 1PB, Hucknall Rd.
关键词
D O I
10.1006/bbrc.1996.0659
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vascular endothelial cell growth factors (VEGF) are key modulators of endothelial cell growth and function. The class III receptor tyrosine kinases KDR and Flt-1 are high-affinity receptors for VEGF, while Flt-4 is a receptor for the recently identified VEGF-C. We have examined the expression of flt-1, flt-4 and KDR in human microvascular and large vessel endothelial cells and in a variety of other cell types in vitro. Endothelial cells proliferated and exhibited increased procoagulant activity in response to VEGF. Flt-1, flt-4 and KDR were detected in both freshly isolated endothelial cells, and in sparse and confluent endothelial cell cultures by RT-PCR. Attempts to modulate receptor expression by culturing cells at reduced oxygen tensions (2%) did not induce consistent changes in flt-1, flt-4 or KDR expression. Incubation with tumor-conditioned medium or co-culture of endothelial cells with a range of breast and small cell lung carcinoma cell lines did not reproducibly alter receptor mRNA expression. However, flt-1, flt-4 and KDR transcript levels were enhanced following treatment with tetradecanoylphorbol acetate. (C) 1996 Academic Press, Inc.
引用
收藏
页码:697 / 702
页数:6
相关论文
共 38 条
[1]  
APRELIKOVA O, 1992, CANCER RES, V52, P746
[2]   DIFFERENTIAL EXPRESSION OF THE 2 VEGF RECEPTORS FLT AND KDR IN PLACENTA AND VASCULAR ENDOTHELIAL-CELLS [J].
BARLEON, B ;
HAUSER, S ;
SCHOLLMANN, C ;
WEINDEL, K ;
MARME, D ;
YAYON, A ;
WEICH, HA .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, 54 (01) :56-66
[3]   NOVEL GROWTH REGULATORY FACTORS AND TUMOR ANGIOGENESIS [J].
BICKNELL, R ;
HARRIS, AL .
EUROPEAN JOURNAL OF CANCER, 1991, 27 (06) :781-785
[4]  
BORG JP, 1995, ONCOGENE, V10, P973
[5]  
BREIER G, 1992, DEVELOPMENT, V114, P521
[6]  
BROCK TA, 1991, AM J PATHOL, V138, P213
[7]   VASCULAR-PERMEABILITY FACTOR - A TUMOR-DERIVED POLYPEPTIDE THAT INDUCES ENDOTHELIAL-CELL AND MONOCYTE PROCOAGULANT ACTIVITY, AND PROMOTES MONOCYTE MIGRATION [J].
CLAUSS, M ;
GERLACH, M ;
GERLACH, H ;
BRETT, J ;
WANG, F ;
FAMILLETTI, PC ;
PAN, YCE ;
OLANDER, JV ;
CONNOLLY, DT ;
STERN, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (06) :1535-1545
[8]   TUMOR VASCULAR-PERMEABILITY FACTOR STIMULATES ENDOTHELIAL-CELL GROWTH AND ANGIOGENESIS [J].
CONNOLLY, DT ;
HEUVELMAN, DM ;
NELSON, R ;
OLANDER, JV ;
EPPLEY, BL ;
DELFINO, JJ ;
SIEGEL, NR ;
LEIMGRUBER, RM ;
FEDER, J .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (05) :1470-1478
[9]   THE FMS-LIKE TYROSINE KINASE, A RECEPTOR FOR VASCULAR ENDOTHELIAL GROWTH-FACTOR [J].
DEVRIES, C ;
ESCOBEDO, JA ;
UENO, H ;
HOUCK, K ;
FERRARA, N ;
WILLIAMS, LT .
SCIENCE, 1992, 255 (5047) :989-991
[10]   WHAT IS THE EVIDENCE THAT TUMORS ARE ANGIOGENESIS DEPENDENT [J].
FOLKMAN, J .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (01) :4-6